Related Experiment Video
Updated: Jul 21, 2026

Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
Published on: August 29, 2022
Hepatitis C in children with chronic kidney disease: A single-center, Egypt
Doaa Mohammed Youssef1, Hanaa Abdo1, Ahmed Alakhras1
1Department of Pediatrics, Zagazig University, Zagazig, Egypt.
Insights
Hepatitis C virus (HCV) infection affects 18% of children with chronic kidney disease (CKD). Longer CKD duration increases HCV risk, potentially worsening kidney function and lowering hemoglobin. Routine HCV screening in pediatric CKD patients is recommended.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Hepatology
Background:
- Hepatitis C virus (HCV) prevalence varies globally, with Egypt reporting the highest rates.
- Chronic kidney disease (CKD) affects children, increasing their susceptibility to comorbidities.
- Understanding HCV prevalence in pediatric CKD is crucial for disease management.
Purpose of the Study:
- To determine the incidence of hepatitis C virus (HCV) infection in children with chronic kidney disease (CKD).
- To investigate the association between HCV infection and clinical/laboratory parameters in pediatric CKD patients.
- To evaluate the impact of HCV infection on CKD progression and associated morbidities.
Main Methods:
- A cross-sectional study involving 50 non-dialysis pediatric CKD patients.
- Comprehensive clinical evaluation, including medical history and physical examination.
- Laboratory assessments included hemoglobin, AST, ALT, urea, creatinine, and eGFR.
- HCV antibody detection using third-generation enzyme immunoassay (EIA).
Main Results:
- Hepatitis C virus (HCV) antibodies were detected in 18% (9 out of 50) of the pediatric CKD cohort.
- HCV-positive children were older, had longer CKD duration, lower eGFR, lower hemoglobin, and higher ALT, urea, and creatinine levels.
- HCV infection correlated with poorer renal function (lower eGFR) and increased hospital admission duration.
Conclusions:
- 18% of children with chronic kidney disease (CKD) are infected with hepatitis C virus (HCV).
- Longer duration of renal disease is a significant risk factor for HCV positivity in this population.
- HCV infection in pediatric CKD may accelerate kidney function decline and negatively impact hemoglobin levels, necessitating routine screening.
Abstract:
Prevalence of hepatitis C varies largely according to geographical distribution, and Egypt so far has the highest prevalence worldwide. The aim of this study was to evaluate hepatitis C infection in chronic kidney disease (CKD) children in our center with regard to its incidence and other morbidities. This is a cross-sectional study involving 50 children with CKD, not on dialysis. All patients underwent a thorough history taking including disease duration and mean duration of admission, clinical examination including blood pressure measurements, and routine laboratory examination such as hemoglobin level, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, and creatinine. The detection of anti-hepatitis C virus (HCV) antibodies was done in all patients based on the use of third-generation enzyme immunoassay (EIA) that detects antibodies directed against various HCV epitopes. Nine (18%) children were found to be hepatitis C positive and 41 were negative to hepatitis C. Infected cases were of older age group and had a longer duration of CKD, lower estimated glomerular filtration rate (eGFR), lower hemoglobin, higher ALT, higher serum urea, and creatinine. We conclude that 18% of children with CKDs have hepatitis C infection, and those with longer the duration of renal disease is more likely to be positive for HCV. Furthermore, HCV infection may predispose to higher deterioration of eGFR, lower hemoglobin level, and more days of admission. We recommend routine testing of HCV in all children with CKD.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Hepatitis